Verum.De Polska Sp. z o.o
Verum.De Polska Sp. z o.o is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Pharmacological treatment of compulsive sexual behaviour disorder
Sponsor Centrum Medycznego Ksztalcenia Podyplomowego
- Start (EU)
- Latest update
- Estimated end
- Not reported
P2-IMU-838-PMS - Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with Progressive Multiple Sclerosis (Calliper)
Sponsor Immunic AG
- Start (EU)
- Latest update
- Estimated end
Phase II, Single-arm Clinical Trial Evaluating Efficacy and Safety of Pembrolizumab in Combination With a Soluble LAG-3 Protein, Eftilagimod Alpha, and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcomas (EFTISARC-NEO)
Sponsor Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Verum.De Polska Sp. z o.o?
The 2026-10-09 snapshot links Verum.De Polska Sp. z o.o to 3 distinct CTIS trials. Recorded services include Clinical monitoring, Regulatory services, CTIS Management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Verum.De Polska Sp. z o.o?
The most frequently recorded therapeutic areas are Immunology, Neurology, Psychiatry. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Verum.De Polska Sp. z o.o conducted?
The linked trials record locations in 6 countries, including Poland, Bulgaria, Czechia, Germany, Netherlands. These are trial locations, not confirmed office locations or countries where Verum.De Polska Sp. z o.o delivered services.
What can this page tell me about Verum.De Polska Sp. z o.o's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Verum.De Polska Sp. z o.o. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Verum.De Polska Sp. z o.o.